Insufficient exclusion of infectious and biofilm-related complications in reported tirzepatide-associated filler nodules
Poramate Pitak-Arnnop · 2026
Read Insufficient exclusion of infectious and biofilm-related complications in reported tirzepatide-associated filler nodules by Poramate Pitak-Arnnop (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13471218.txt.
Description
Poramate Pitak-Arnnop writes in 2026, in a letter to the editor, questioning a report that tied recurrent facial nodules after filler injections to the drug tirzepatide. The original authors had proposed a sterile inflammatory reaction to the compounded drug. Pitak-Arnnop argues the case was closed too early, because no microbiological cultures or tissue examinations were ever performed.
Swelling that switches on and off across several injection sites, the letter notes, is not specific to a drug reaction. The same pattern fits an infectious cause, such as a slow growing contaminant introduced during injections. Without samples grown in a lab or examined under a microscope, the two explanations cannot be separated. The letter presses for definitive testing before the inflammatory account is accepted. It is the counterpoint to a reply published by the original team.
Catalog record
| CREATOR | Poramate Pitak-Arnnop |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2214 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |